发明名称 AZABENZIMIDAZOLONES
摘要 Compounds are provided having the general structure of formula I: In formula I, one member of the group (W, X, Y and Z) is a nitrogen atom and the remaining three members of the group are each independently a carbon atom covalently bonded to a radical, R4. The radicals, R1 R2, R3 and R4 are each defined herein, and n is an integer from 1 to 4. Also provided are stereoisomers, prodrugs, pharmaceutically acceptable salts, hydrates, salt hydrates, acid salt hydrates, and polymorphs of the compounds having the structure of formula I. The compounds bind the prostaglandin D2 receptor and are useful in the prophylaxis and treatment of prostaglandin D2-mediated diseases and conditions, including pain and inflammation, as well as asthma and allergic diseases and conditions.
申请公布号 WO2010045276(A3) 申请公布日期 2010.08.19
申请号 WO2009US60574 申请日期 2009.10.14
申请人 CARA THERAPEUTICS, INC.;LUO, ROBERT, ZHIYONG;ZABLOCKI, MARY-MARGARET 发明人 LUO, ROBERT, ZHIYONG;ZABLOCKI, MARY-MARGARET
分类号 C07D401/04;A61K31/4162;A61P27/14;A61P37/08;C07D403/04;C07D487/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址